Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells

Molecular and Cellular Endocrinology

Volumn 235, Issue 1-2, 2005, Pages 39-50

  Mrusek, S ^a   Classen Linke, I ^a   Vloet, A ^a   Beier, H M ^a   Krusche, C A ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Breast cancer; Estrogen; Gene regulation; Progestins; T47D Cell line

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ARTICLE; BIOSYNTHESIS; BREAST CARCINOMA; CANCER CELL; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 18144403817     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.01.009     Document Type: Article

References (50)

1. M. Alkhalaf, A. El-Mowafy, and S. Karam Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein Eur. J. Cancer Prev. 11 2002 481 488
2. T. Bratt Lipocalins and cancer Biochim. Biophys. Acta 1482 2000 318 326
3. C. Brisken, S. Park, T. Vass, J.P. Lydon, B.W. O'Malley, and R.A. Weinberg A paracrine role for the epithelial progesterone receptor in mammary gland development Proc. Natl. Acad. Sci. U.S.A. 95 1998 5076 5081
4. N.J. Bundred, W.R. Miller, and R.A. Walker An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha2 glycoprotein Histopathology 11 1987 603 610
5. E. Carballo, G.S. Gilkeson, and P.J. Blackshear Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction J. Clin. Invest. 100 1997 986 995
6. R.W. Carlson Sequencing of endocrine therapies in breast cancer - integration of recent data Breast Cancer Res. Treat. 75 2002 S27 S32
7. D. Chalbos, and H. Rochefort Dual effects of the progestin R5020 on protein release by the T47D human breast cancer cells J. Biol. Chem. 259 1984 1231 1238
8. O.M. Conneely, B. Mulac-Jericevic, F. DeMayo, J.P. Lydon, and B.W. O'Malley Reproductive functions of progesterone receptors Recent Prog. Horm. Res. 57 2002 339 355
9. L.S. Cooper, C.E. Gillett, N.K. Patel, D.M. Barnes, and I.S. Fentiman Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor Cancer 15 1999 2053 2058
10. J.S. De Jong, P.J. van Diest, P. van der Valk, and J.P. Baak Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops J. Pathol. 184 1998 44 52
11. B. DeLignieres Effects of progestrogens on the postmenopausal breast Climacteric 5 2002 229 235
12. L.J. Duncan, and M.J. Reed The role and proposed mechanism by which oestradiol 17 beta-hydroxysteroid dehydrogenase regulates breast tumor oestrogen concentrations J. Steroid Biochem. Mol. Biol. 55 1995 565 572
13. P.H. Giangrande, E.A. Kimbrel, D.P. Edwards, and D.P. McDonnell The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding Mol. Cell. Biol. 20 2000 3102 3115
14. J.D. Graham, S.M.N. Hunt, N. Tran, and C.L. Clarke Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators J. Mol. Endocrinol. 22 1999 295 304
15. M.L. Graham, K.E. Dalquist, and K.B. Horwitz Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line Cancer Res. 49 1989 3943 3949
16. R.J. Griffin, B.W. Williams, R. Wild, J.M. Cherrington, H. Park, and C.W. Song Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res. 62 2002 1702 1706
17. A.A. Hagen, and W.J.M. Hrushesky Menstrual timing of breast cancer surgery Am. J. Surg. 104 1998 245 261
18. R.C. Hovey, J.F. Trott, and B.K. Vonderhaar Establishing a framework for the functional mammary gland: from endocrinology to morphology J. Mammary Gland Biol. Neoplasia 7 2002 17 38
19. G. Hudelist, K. Czerwenka, E. Kubista, E. Marton, K. Pischinger, and C.F. Singer Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator Breast Cancer Res. Treat. 78 2003 193 204
20. E. Isaksson, E. von Schoultz, V. Odlind, G. Soderqvist, G. Csemiczky, K. Carlstrom, L. Skoog, and B. von Schoultz Effects of oral contraceptives on breast epithelial proliferation Breast Cancer Res. Treat. 65 2001 163 169
21. P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, and P. Chambon Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO J. 9 1990 1603 1614
22. H.A. Kester, B.M. van der Leede, P.T. van der Saag, and B. van der Burg Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation J. Biol. Chem. 272 1997 16637 16643
23. F. Kommoss, M. Colley, C.E. Hart, and W.A. Franklin In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit Mol. Cell Probes 4 1990 11 23
24. Krusche, C.A., Wuelfing, P., Kersting, C., Vloet, A., Boecker, W., Kiesel, L., Beier, H.M., Alfer, J., in press. Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis. Breast Cancer Res. Treat.
25. C. Lanari, and A.A. Molinolo Progesterone receptors - animal models and cell signalling in breast cancer: diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer Breast Cancer Res. 4 2002 240 243
26. C.A. Lange, J.K. Richer, and K.B. Horwitz Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals Mol. Endocrinol. 13 1999 829 836
27. R.D. Leek, R. Landers, S.B. Fox, F. Ng, A.L. Harris, and C.E. Lewis Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma Br. J. Cancer 77 1998 2246 2251
28. G. Leung, S.W. Tsao, and Y.C. Wong Sex hormone-induced mammary carcinogenesis in female Noble rats: detection of differentially expressed genes Breast Cancer Res. Treat. 77 2003 49 63
29. L. Liao, S.Q. Kuang, Y. Yuan, S.M. Gonzalez, B.W. O'Malley, and J. Xu Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1 J. Steroid Biochem. Mol. Biol. 85 2002 3 14
30. V.C.L. Lin, R. Jin, P.H. Tan, S.E. Aw, C.T. Woon, and B.H. Bay Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA Am. J. Pathol. 162 2003 1781 1787
31. Y.S. Lopez-Boado, I. Diez-Itza, J. Tolivia, and C. Lopez-Otin Glucocorticoids and androgens up-regulate the Zn-α2-glycoprotein messenger RNA in human breast cancer cells Breast Cancer Res. Treat. 29 1994 247 258
32. K. McPherson, C.M. Steel, and J.M. Dixon ABC of breast diseases. Breast cancer epidemiology, risk factors, and genetics Br. Med. J. 321 2000 624 628
33. L. Meng, J. Zhou, H. Sasano, T. Suzuki, K.M. Zeitoun, and S.E. Bulun Tumor necrosis factor α and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ: mechanism of desmoplastic reaction Cancer Res. 61 2001 2250 2255
34. K.I. Pritchard Endocrine therapy of advanced disease: analysis and implications of existing data Clin. Can. Res. (Suppl.) 9 2003 460s 467s
35. A. Raghavan, R.L. Robison, J. McNabb, C.R. Miller, D.A. Williams, and P.R. Bohjanen HuA and tristetraprolin are induced following T cell activation and display distinct overlapping RNA binding specificities J. Biol. Chem. 276 2001 47958 47965
36. R.R. Reddel, I.E. Alexander, M. Koga, J. Shine, and R.L. Sutherland Genetic instability and the development of steroid hormone insensitivity in cultured T47D human breast cancer cells Cancer Res. 48 1988 4340 4347
37. J.K. Richer, B.M. Jacobsen, N.G. Manning, M.G. Abel, D.M. Wolf, and K.B. Horwitz Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells J. Biol. Chem. 277 2002 5209 5218
38. B.G. Rowan, and B.W. O'Malley Progesterone receptor coactivators Steroids 65 2000 545 549
39. Z.M. Shao, M. Nguyen, and S.H. Barsky Human breast carcinoma desmoplasia is PDGF initiated Oncogene 19 2000 4337 4345
40. D.B. Shennan, and M. Peaker Transport of milk constituents by the mammary gland Physiol. Rev. 80 2000 925 951
41. Y.E. Shi, J. Torri, L. Yieh, M.E. Sobel, Y. Yamada, M.E. Lippman, R.B. Dickson, and E.W. Thompson Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins Clin. Exp. Metast. 11 1993 251 261
42. S. Soyal, P.M. Ismail, J. Li, B. Mulac-Jericevic, O.M. Conneely, and J.P. Lydon Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics Breast Cancer Res. 4 2002 191 196
43. S.P. Stoesz, A. Friedl, J.D. Haag, M.J. Lindstrom, G.M. Clark, and M.N. Gould Heterogenous expression of the lipocalin NGAL in primary breast cancers Int. J. Cancer 79 1998 565 572
44. S. Thiagalingam, K.H. Cheng, H. Lee, N. Mineva, A. Thiagalingam, and J.F. Ponte Histone deacetylases: unique players in shaping the epigenetic histone code Ann. NY Acad. Sci. 983 2003 84 100
45. C. Underhill, M.S. Qutob, S.P. Yes, and J. Torchia A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1 J. Biol. Chem. 51 2000 40463 40470
46. D.M. Vigushin, S. Ali, P.E. Pace, N. Mirsaidi, K. Ito, I. Adcock, and R.C. Coombes Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo Clin. Cancer Res. 7 2001 971 976
47. R.A. Walker The complexities of breast cancer desmoplasia Breast Cancer Res. 3 2001 143 145
48. L.K. Weiss, R.T. Burkman, K.L. Cushing-Haugen, L.F. Voigt, M.S. Simon, J.R. Daling, S.A. Norman, L. Bernstein, G. Ursin, and P.A. Marchbanks Hormone replacement therapy regimens and breast cancer risk Obstet. Gynecol. 100 2002 1148 1158
49. L. Yan, N. Borregaard, L. Kjeldsen, and M.A. Moses The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) J. Biol. Chem. 276 2001 37258 37265
50. N. Yoshida, Y. Omoto, A. Inoue, H. Eguchi, Y. Kobayashi, M. Kurosumi, S. Saji, K. Suemasu, T. Okazaki, K. Nakachi, T. Fujita, and S. Hayashi Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes Cancer Sci. 95 2004 496 502